Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	solute:monoatomic cation symporter activity	SLC12A6 SLC2A4 SLC5A3 SLC6A2 SLC20A1 SLC6A20 SLC4A4	3.40e-05	119	151	7	GO:0015294
GeneOntologyMolecularFunction	G protein activity	MRAS GBP2 RIT2 RIT1 GNA13	8.34e-05	59	151	5	GO:0003925
GeneOntologyMolecularFunction	GDP binding	RRAS2 MRAS GBP2 RRAS RIT2 RIT1	1.32e-04	103	151	6	GO:0019003
GeneOntologyMolecularFunction	symporter activity	SLC12A6 SLC2A4 SLC5A3 SLC6A2 SLC20A1 SLC6A20 SLC4A4	1.47e-04	150	151	7	GO:0015293
GeneOntologyMolecularFunction	ATP-dependent chromatin remodeler activity	ATRX CHD1 CHD7 ARID1A	1.71e-04	37	151	4	GO:0140658
GeneOntologyMolecularFunction	solute:sodium symporter activity	SLC5A3 SLC6A2 SLC20A1 SLC6A20 SLC4A4	3.73e-04	81	151	5	GO:0015370
GeneOntologyCellularComponent	integrin complex	ITGA8 ITGA2 ITGA4 ITGAD	8.25e-05	32	152	4	GO:0008305
GeneOntologyCellularComponent	anchoring junction	RRAS2 HSP90B1 NRAP COL17A1 PDGFRB ITGA8 LAMA3 ITGA2 PTPRU ITGA4 RRAS NPHP4 TSPAN33 NOX1 PCDHGA12 GNA13 PRKCZ ATP1A2 PACSIN2	8.87e-05	976	152	19	GO:0070161
GeneOntologyCellularComponent	cell-substrate junction	RRAS2 HSP90B1 NRAP COL17A1 PDGFRB ITGA8 LAMA3 ITGA2 ITGA4 RRAS GNA13 PACSIN2	9.92e-05	443	152	12	GO:0030055
HumanPheno	Myeloid leukemia	RRAS2 MRAS IDH1 RRAS F13A1 RIT1	5.73e-07	31	53	6	HP:0012324
HumanPheno	Aplasia of the semicircular canal	RRAS2 MRAS CHD7 RRAS RIT1	7.78e-07	18	53	5	HP:0011381
HumanPheno	Postnatal growth retardation	SOX2 RRAS2 MRAS ATRX CHD1 CHD7 RRAS ARID1A RIT1 ARID1B PIEZO2 TAF1 MBD5	1.46e-06	258	53	13	HP:0008897
HumanPheno	Abnormal semicircular canal morphology	RRAS2 MRAS CHD7 RRAS RIT1	5.61e-06	26	53	5	HP:0011380
HumanPheno	Abnormal morphology of the vestibule of the inner ear	RRAS2 MRAS CHD7 RRAS RIT1	1.91e-05	33	53	5	HP:0011376
HumanPheno	Juvenile myelomonocytic leukemia	RRAS2 MRAS RRAS RIT1	2.87e-05	18	53	4	HP:0012209
HumanPheno	Delayed menarche	RRAS2 MRAS RRAS RIT1	7.99e-05	23	53	4	HP:0012569
HumanPheno	Short digit	RRAS2 MRAS ATRX PDGFRB CHD7 IDH1 PLXND1 RRAS ARID1A RIT1 SNX14 ARID1B PIEZO2 RIN2 PRKCZ TAF1 MBD5 CNOT1	8.32e-05	672	53	18	HP:0011927
HumanPheno	Transient unilateral blurring of vision	CACNA1A ATP1A2	1.06e-04	2	53	2	HP:0001125
HumanPheno	Thickened helices	RRAS2 MRAS RRAS RIT1 TAF1	1.11e-04	47	53	5	HP:0000391
HumanPheno	Cystic hygroma	RRAS2 MRAS PLXND1 RRAS RIT1	1.81e-04	52	53	5	HP:0000476
Domain	Integrin_alpha_C_CS	ITGA8 ITGA2 ITGA4 ITGAD	6.93e-06	16	151	4	IPR018184
Domain	RAS	RRAS2 MRAS RRAS RIT2 RIT1	8.63e-06	35	151	5	PS51421
Domain	Small_GTPase_Ras	RRAS2 MRAS RRAS RIT2 RIT1	1.14e-05	37	151	5	IPR020849
Domain	Integrin_alpha-2	ITGA8 ITGA2 ITGA4 ITGAD	1.15e-05	18	151	4	IPR013649
Domain	INTEGRIN_ALPHA	ITGA8 ITGA2 ITGA4 ITGAD	1.15e-05	18	151	4	PS00242
Domain	Integrin_alpha2	ITGA8 ITGA2 ITGA4 ITGAD	1.15e-05	18	151	4	PF08441
Domain	Integrin_alpha	ITGA8 ITGA2 ITGA4 ITGAD	1.15e-05	18	151	4	IPR000413
Domain	Int_alpha	ITGA8 ITGA2 ITGA4 ITGAD	1.45e-05	19	151	4	SM00191
Domain	Int_alpha_beta-p	ITGA8 ITGA2 ITGA4 ITGAD	1.45e-05	19	151	4	IPR013519
Domain	FG_GAP	ITGA8 ITGA2 ITGA4 ITGAD	2.68e-05	22	151	4	PS51470
Domain	FG-GAP	ITGA8 ITGA2 ITGA4 ITGAD	3.85e-05	24	151	4	PF01839
Domain	FG-GAP	ITGA8 ITGA2 ITGA4 ITGAD	3.85e-05	24	151	4	IPR013517
Domain	Integrin_dom	ITGA8 ITGA2 ITGA4 ITGAD	4.55e-05	25	151	4	IPR032695
Domain	BAF250/Osa	ARID1A ARID1B	6.49e-05	2	151	2	IPR021906
Domain	BAF250_C	ARID1A ARID1B	6.49e-05	2	151	2	IPR033388
Domain	BAF250_C	ARID1A ARID1B	6.49e-05	2	151	2	PF12031
Domain	Integrin_alpha	ITGA8 ITGA4 ITGAD	8.15e-05	11	151	3	PF00357
Domain	PXA	SNX13 SNX14	3.85e-04	4	151	2	SM00313
Domain	AbLIM_anchor	ABLIM1 ABLIM2	3.85e-04	4	151	2	PF16182
Domain	PXA	SNX13 SNX14	3.85e-04	4	151	2	PS51207
Domain	PXA	SNX13 SNX14	3.85e-04	4	151	2	PF02194
Domain	Sorting_nexin_C	SNX13 SNX14	3.85e-04	4	151	2	IPR013937
Domain	AbLIM_anchor	ABLIM1 ABLIM2	3.85e-04	4	151	2	IPR032402
Domain	Phox_assoc	SNX13 SNX14	3.85e-04	4	151	2	IPR003114
Domain	Nexin_C	SNX13 SNX14	3.85e-04	4	151	2	PF08628
Domain	P-loop_NTPase	TPST1 RRAS2 MRAS GTPBP6 ATRX MYO5A MYO5B GBP2 CHD1 CHD7 RRAS RIT2 RIT1 CIITA SBNO1 GNA13 DHX32	5.11e-04	848	151	17	IPR027417
Domain	VWFA	PSMD4 COL6A5 ITGA2 ITGAD ITIH1	5.35e-04	82	151	5	PS50234
Domain	VWA	PSMD4 COL6A5 ITGA2 ITGAD ITIH1	5.97e-04	84	151	5	SM00327
Domain	Myosin_S1_N	MYO5A MYO5B	6.39e-04	5	151	2	IPR008989
Domain	SOXp	SOX1 SOX2	6.39e-04	5	151	2	PF12336
Domain	SOX_fam	SOX1 SOX2	6.39e-04	5	151	2	IPR022097
Domain	Dilute_dom	MYO5A MYO5B	9.53e-04	6	151	2	IPR002710
Domain	HSF_fam	HSF2 HSF4	9.53e-04	6	151	2	IPR027725
Domain	DIL	MYO5A MYO5B	9.53e-04	6	151	2	PF01843
Domain	DILUTE	MYO5A MYO5B	9.53e-04	6	151	2	PS51126
Domain	DIL	MYO5A MYO5B	9.53e-04	6	151	2	SM01132
Domain	VWA	COL6A5 ITGA2 ITGAD ITIH1	1.09e-03	56	151	4	PF00092
Domain	VWF_A	PSMD4 COL6A5 ITGA2 ITGAD ITIH1	1.26e-03	99	151	5	IPR002035
Domain	HSF_DNA-bind	HSF2 HSF4	1.33e-03	7	151	2	PF00447
Domain	HSF_DOMAIN	HSF2 HSF4	1.33e-03	7	151	2	PS00434
Domain	HSF_DNA-bd	HSF2 HSF4	1.33e-03	7	151	2	IPR000232
Domain	HSF	HSF2 HSF4	1.33e-03	7	151	2	SM00415
Domain	DAD_dom	FHOD3 DIAPH3	1.76e-03	8	151	2	IPR014767
Domain	HP	ABLIM1 ABLIM2	1.76e-03	8	151	2	PS51089
Domain	-	ABLIM1 ABLIM2	1.76e-03	8	151	2	1.10.950.10
Domain	DAD	FHOD3 DIAPH3	1.76e-03	8	151	2	PS51231
Domain	VHP	ABLIM1 ABLIM2	1.76e-03	8	151	2	SM00153
Domain	VHP	ABLIM1 ABLIM2	1.76e-03	8	151	2	PF02209
Domain	Villin_headpiece	ABLIM1 ABLIM2	1.76e-03	8	151	2	IPR003128
Domain	SNF2_N	ATRX CHD1 CHD7	2.16e-03	32	151	3	IPR000330
Domain	SNF2_N	ATRX CHD1 CHD7	2.16e-03	32	151	3	PF00176
Pathway	KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	RRAS2 MRAS PDGFRB ITGA8 ITGA2 ITGA4 RRAS ITGAD GNA13 DIAPH3	1.59e-05	213	122	10	M18306
Pathway	KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY	ARHGEF28 ITGA8 ITGA2 ITGA4	4.16e-05	23	122	4	M47720
Pathway	PID_INTEGRIN_CS_PATHWAY	ITGA8 ITGA2 ITGA4 ITGAD	6.89e-05	26	122	4	M47
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	PEG10 POLR2B TFIP11 CHD1 PAF1 ARID1A LENG8 ARID1B NDC1 SBNO1 ZC3H4 ZNF638 MRTO4 TRMT5	4.08e-10	341	153	14	32971831
Pubmed	A human MAP kinase interactome.	HSP90B1 LAMA3 PPP1R13B PSMD4 NCKAP5L LENG8 ABLIM1 ATF7IP PRKCE PRKCZ TAF1 SLC4A4 USF2 ABLIM2 MBD5 PACSIN2	5.48e-10	486	153	16	20936779
Pubmed	Human transcription factor protein interaction networks.	SOX2 ATRX MYO5A ACTR5 NACC1 PEG10 PPP1R13B PSMD4 TFIP11 CHD7 ARID1A LENG8 ARID1B PRRC2C ATF7IP EPC1 ZNF638 MRTO4 TAF1 SNRNP70 SMAP2 CNOT1 PACSIN2	7.87e-08	1429	153	23	35140242
Pubmed	Comparative expression of the mouse Sox1, Sox2 and Sox3 genes from pre-gastrulation to early somite stages.	SOX1 SOX2 ITIH1	3.33e-07	4	153	3	10446282
Pubmed	R-Ras1 and R-Ras2 Are Essential for Oligodendrocyte Differentiation and Survival for Correct Myelination in the Central Nervous System.	RRAS2 MRAS RRAS	3.33e-07	4	153	3	29720552
Pubmed	Noonan Syndrome	RRAS2 MRAS RRAS RIT1	4.73e-07	15	153	4	20301303
Pubmed	PDGF signalling in the dermis and in dermal condensates is dispensable for hair follicle induction and formation.	SOX2 PDGFRB ITGA8	8.29e-07	5	153	3	25708924
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	CACNA1A MYO5A NACC1 CHD7 GRIN2D PAF1 ITIH1 ABLIM1 UBR5 ZC3H4 PRRC2C ATF7IP SPHKAP ELAVL3 PRKCE SLC4A4 CNOT1	1.31e-06	963	153	17	28671696
Pubmed	Fezl regulates the differentiation and axon targeting of layer 5 subcortical projection neurons in cerebral cortex.	SOX2 NPR3 PLXND1 PTPRU RORB DIAPH3 CDON	1.51e-06	126	153	7	16284245
Pubmed	Activation of the epidermal growth factor receptor signal transduction pathway stimulates tyrosine phosphorylation of protein kinase C delta.	PRKCE PRKCZ FYN	1.65e-06	6	153	3	8621384
Pubmed	Characterization of R-ras3/m-ras null mice reveals a potential role in trophic factor signaling.	RRAS2 MRAS RRAS	1.65e-06	6	153	3	16980617
Pubmed	Sox2 modulates the function of two distinct cell lineages in mouse skin.	SOX2 CACNA1A PCLO ITGA8	2.03e-06	21	153	4	23948231
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	HSP90B1 TTC28 PPP1R13B ARID1A LENG8 ABLIM1 NDC1 ZNF638 CNOT1	2.72e-06	263	153	9	34702444
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	RRAS2 HSP90B1 MYO5A MYO5B POLR2B CHD1 ABLIM1 NDC1 UBR5 ZC3H4 SLC20A1 GNA13 ZNF638 MRTO4 SNRNP70 FYN CNOT1	2.98e-06	1024	153	17	24711643
Pubmed	Network organization of the huntingtin proteomic interactome in mammalian brain.	SLC12A6 HSP90B1 MYO5A MYO5B PCLO CHD1 ITIH1 GNA13 ELAVL3 PRKCE GAPDHS FYN PACSIN2	4.05e-06	621	153	13	22794259
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	HSP90B1 MYO5A MYO5B POLR2B PPP1R13B PSMD4 PTPRU PAF1 PPP1R13L ARID1A NCKAP5L MTMR7 ARID1B NDC1 VPS13A ZNF638 CNOT1	4.10e-06	1049	153	17	27880917
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	EPHB6 POLR2B PLXND1 PTPRU ARID1A FRK MTMR7 ARID1B PRKCE PRKCZ TAF1 ATP1A2 MMP16 FYN	4.65e-06	730	153	14	34857952
Pubmed	Analysis of the myosin-II-responsive focal adhesion proteome reveals a role for β-Pix in negative regulation of focal adhesion maturation.	RRAS2 HSP90B1 PDGFRB ITGA8 ITGA2 ITGA4 RRAS GNA13 PACSIN2	5.23e-06	285	153	9	21423176
Pubmed	Perlecan regulates pericyte dynamics in the maintenance and repair of the blood-brain barrier.	ITGA8 ITGA2 ITGA4 ITGAD	5.84e-06	27	153	4	31541017
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	TTC28 POLR2B PPP1R13B TFIP11 PAF1 ARID1A ABLIM1 ARID1B PRRC2C TAF1 DIAPH3 CNOT1	6.25e-06	549	153	12	38280479
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	ARHGEF28 ATRX NACC1 POLR2B PSMD4 CHD1 TNFRSF17 LENG8 SNX14 UBR5 SBNO1 POLR1E SLC20A1 GNA13 EPC1 DIAPH3 USF2 CNOT1 LCMT1	6.40e-06	1327	153	19	32694731
Pubmed	The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1.	RRAS2 MRAS RRAS	6.88e-06	9	153	3	11857081
Pubmed	Prediction of the coding sequences of unidentified human genes. XIV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	BTBD8 TTC28 PEG10 ZC3H4 PRRC2C SV2C	6.99e-06	104	153	6	10470851
Pubmed	Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.	SOX2 EPHB6 ZCCHC9 MRAS GTPBP6 PDGFRB CHD1 ADAM11 ITGA2 PTPRU NCKAP5L LENG8 PIEZO2 ZC3H4 EPC1 VPS13A SNRNP70 PACSIN2	7.21e-06	1215	153	18	15146197
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	PCLO PSMD4 CHD7 ARID1A NCKAP5L ARID1B ATF7IP EPC1 TAF1 PACSIN2	1.16e-05	398	153	10	35016035
Pubmed	Regulation of endodermal differentiation of human embryonic stem cells through integrin-ECM interactions.	ITGA8 LAMA3 ITGA2 ITGA4	1.18e-05	32	153	4	23154389
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	ATRX TTC28 PPP1R13B CHD7 PAF1 ARID1A NCKAP5L UBR5 PRRC2C ATF7IP DIAPH3 HSF2	1.24e-05	588	153	12	38580884
Pubmed	Functional proteomics mapping of a human signaling pathway.	ATRX PEG10 PPP1R13B PPP1R13L ARID1B UBR5 ATF7IP POLI DIAPH3 SNRNP70 GGA1 SDK1	1.30e-05	591	153	12	15231748
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	SLC12A6 NRAP MYOM1 PEG10 PAF1 ABLIM1 ARID1B APPL2 MRTO4 TAF1 ABLIM2	1.37e-05	497	153	11	23414517
Pubmed	Radial glia require PDGFD-PDGFRβ signalling in human but not mouse neocortex.	SOX1 SOX2 PDGFRB ITGA2	1.51e-05	34	153	4	25391964
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	EPHB6 HSP90B1 GTPBP6 ATRX TTC28 MYO5A PDGFRB PEG10 PSMD4 TFIP11 ARID1A ABLIM1 APPL2 SBNO1 RORB TAF1 ATP1A2 SNRNP70	1.53e-05	1285	153	18	35914814
Pubmed	Multiple roles of integrin-α3 at the neuromuscular junction.	CACNA1A PCLO SV2C	1.78e-05	12	153	3	28386022
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	CACNA1A SLC12A6 HSP90B1 BTBD8 MYO5A MYO5B PCLO ITGA2 ARID1A ABLIM1 APPL2 PRRC2C ELAVL3 PRKCE SAMM50 ATP1A2 SLC4A4 ABLIM2 CNOT1	1.84e-05	1431	153	19	37142655
Pubmed	RIT1 GTPase Regulates Sox2 Transcriptional Activity and Hippocampal Neurogenesis.	SOX2 RIT1	1.92e-05	2	153	2	28007959
Pubmed	Genetics and development of ocular oxidases in the mouse: evidence for a new locus (Eox-1) closely linked with the aldehyde oxidase loci on chromosome 1.	AOX1 IDH1	1.92e-05	2	153	2	3207217
Pubmed	PKCε regulates contraction-stimulated GLUT4 traffic in skeletal muscle cells.	SLC2A4 PRKCE	1.92e-05	2	153	2	20658540
Pubmed	Heat shock factor 4a (HSF4a) represses HSF2 expression and HSF2-mediated transcriptional activity.	HSF2 HSF4	1.92e-05	2	153	2	21792930
Pubmed	No genetic association between Fyn kinase gene polymorphisms (-93A/G, IVS10+37T/C and Ex12+894T/G) and Japanese sporadic Alzheimer's disease.	FRK FYN	1.92e-05	2	153	2	15082191
Pubmed	The R-Ras/RIN2/Rab5 complex controls endothelial cell adhesion and morphogenesis via active integrin endocytosis and Rac signaling.	RRAS RIN2	1.92e-05	2	153	2	22825554
Pubmed	Sequence requirements for binding of Src family tyrosine kinases to activated growth factor receptors.	PDGFRB FYN	1.92e-05	2	153	2	7730365
Pubmed	H3K27M, IDH1, and ATRX expression in pediatric GBM and their clinical and prognostic significance.	ATRX IDH1	1.92e-05	2	153	2	31152217
Pubmed	Dissecting the role of SWI/SNF component ARID1B in steady-state hematopoiesis.	ARID1A ARID1B	1.92e-05	2	153	2	37611161
Pubmed	Subunits of ARID1 serve as novel biomarkers for the sensitivity to immune checkpoint inhibitors and prognosis of advanced non-small cell lung cancer.	ARID1A ARID1B	1.92e-05	2	153	2	32791957
Pubmed	SOX 1, contrary to SOX 2, suppresses proliferation, migration, and invasion in human laryngeal squamous cell carcinoma by inhibiting the Wnt/β-catenin pathway.	SOX1 SOX2	1.92e-05	2	153	2	26040764
Pubmed	Semaphorin4A-Plexin D1 Axis Induces Th2 and Th17 While Represses Th1 Skewing in an Autocrine Manner.	PLXND1 SEMA4A	1.92e-05	2	153	2	32971928
Pubmed	RIC, a calmodulin-binding Ras-like GTPase.	RIT2 RIT1	1.92e-05	2	153	2	8918462
Pubmed	Screen for CACNA1A and ATP1A2 mutations in sporadic hemiplegic migraine patients.	CACNA1A ATP1A2	1.92e-05	2	153	2	18513263
Pubmed	Suppression of the antiviral response by an influenza histone mimic.	CHD1 PAF1	1.92e-05	2	153	2	22419161
Pubmed	Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers.	ARID1A ARID1B	1.92e-05	2	153	2	28967863
Pubmed	PDGF-induced phosphorylation of Tyr28 in the N-terminus of Fyn affects Fyn activation.	PDGFRB FYN	1.92e-05	2	153	2	9425276
Pubmed	Mutant IDH1 Cooperates with ATRX Loss to Drive the Alternative Lengthening of Telomere Phenotype in Glioma.	ATRX IDH1	1.92e-05	2	153	2	29545335
Pubmed	The mouse liver aldehyde oxidase locus (Aox).	AOX1 IDH1	1.92e-05	2	153	2	4269806
Pubmed	Detection of ATRX and IDH1-R132H immunohistochemistry in the progression of 211 paired gliomas.	ATRX IDH1	1.92e-05	2	153	2	26918938
Pubmed	GPRC5B activates obesity-associated inflammatory signaling in adipocytes.	FYN GPRC5B	1.92e-05	2	153	2	23169819
Pubmed	Mutation analysis of CACNA1A and ATP1A2 genes in Brazilian FHM families.	CACNA1A ATP1A2	1.92e-05	2	153	2	17119788
Pubmed	Dual ARID1A/ARID1B loss leads to rapid carcinogenesis and disruptive redistribution of BAF complexes.	ARID1A ARID1B	1.92e-05	2	153	2	34386776
Pubmed	Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma.	ARID1A ARID1B	1.92e-05	2	153	2	23202128
Pubmed	ARID1 proteins: from transcriptional and post-translational regulation to carcinogenesis and potential therapeutics.	ARID1A ARID1B	1.92e-05	2	153	2	33890484
Pubmed	No mutations in CACNA1A and ATP1A2 in probands with common types of migraine.	CACNA1A ATP1A2	1.92e-05	2	153	2	15210532
Pubmed	Csk inhibition of c-Src activity requires both the SH2 and SH3 domains of Src.	PDGFRB FYN	1.92e-05	2	153	2	7687537
Pubmed	R-Ras1 and R-Ras2 Expression in Anatomical Regions and Cell Types of the Central Nervous System.	RRAS2 RRAS	1.92e-05	2	153	2	35055164
Pubmed	Platelet-derived growth factor receptor sequences important for binding of src family tyrosine kinases.	PDGFRB FYN	1.92e-05	2	153	2	1661130
Pubmed	ARID1B is a specific vulnerability in ARID1A-mutant cancers.	ARID1A ARID1B	1.92e-05	2	153	2	24562383
Pubmed	Absence of R-Ras1 and R-Ras2 causes mitochondrial alterations that trigger axonal degeneration in a hypomyelinating disease model.	RRAS2 RRAS	1.92e-05	2	153	2	33010069
Pubmed	Acute Lymphoblastic Leukemia Patient with Variant ATF7IP/PDGFRB Fusion and Favorable Response to Tyrosine Kinase Inhibitor Treatment: A Case Report.	PDGFRB ATF7IP	1.92e-05	2	153	2	29133777
Pubmed	Chd7 Collaborates with Sox2 to Regulate Activation of Oligodendrocyte Precursor Cells after Spinal Cord Injury.	SOX2 CHD7	1.92e-05	2	153	2	28931573
Pubmed	Combined ATRX/IDH1 immunohistochemistry predicts genotype of oligoastrocytomas.	ATRX IDH1	1.92e-05	2	153	2	26016385
Pubmed	Association between the PDGF receptor and members of the src family of tyrosine kinases.	PDGFRB FYN	1.92e-05	2	153	2	1696179
Pubmed	R-Ras is required for murine dendritic cell maturation and CD4+ T-cell priming.	RRAS2 RRAS	1.92e-05	2	153	2	22174156
Pubmed	The CACNA1A and ATP1A2 genes are not involved in dominantly inherited migraine with aura.	CACNA1A ATP1A2	1.92e-05	2	153	2	16508934
Pubmed	ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma.	ARID1A ARID1B	1.92e-05	2	153	2	29890703
Pubmed	Selective integrin endocytosis is driven by interactions between the integrin α-chain and AP2.	ITGA2 ITGA4	1.92e-05	2	153	2	26779610
Pubmed	Genetics, ontogeny, and testosterone inducibility of aldehyde oxidase isozymes in the mouse: evidence for two genetic loci (Aox-I and Aox-2) closely linked on chromosome 1.	AOX1 IDH1	1.92e-05	2	153	2	518535
Pubmed	Noninvasive Prediction of IDH1 Mutation and ATRX Expression Loss in Low-Grade Gliomas Using Multiparametric MR Radiomic Features.	ATRX IDH1	1.92e-05	2	153	2	30194745
Pubmed	Absence of alpha 4 but not beta 2 integrins restrains development of chronic allergic asthma using mouse genetic models.	ITGA2 ITGA4	1.92e-05	2	153	2	19463772
Pubmed	SWI/SNF factors required for cellular resistance to DNA damage include ARID1A and ARID1B and show interdependent protein stability.	ARID1A ARID1B	1.92e-05	2	153	2	24788099
Pubmed	Establishment and characterization of VOA1066 cells: An undifferentiated endometrial carcinoma cell line.	ARID1A ARID1B	1.92e-05	2	153	2	33052929
Pubmed	Role of protein kinase C and mitochondrial permeability transition pore in the neuroprotective effect of ceramide in ischemia-induced cell death.	PRKCE PRKCZ	1.92e-05	2	153	2	21081127
Pubmed	Reactive oxygen species derived from NOX1/NADPH oxidase enhance inflammatory pain.	NOX1 PRKCE	1.92e-05	2	153	2	18799680
Pubmed	De novo mutations in ATP1A2 and CACNA1A are frequent in early-onset sporadic hemiplegic migraine.	CACNA1A ATP1A2	1.92e-05	2	153	2	20837964
Pubmed	NF-κB-induced NOX1 activation promotes gastric tumorigenesis through the expansion of SOX2-positive epithelial cells.	SOX2 NOX1	1.92e-05	2	153	2	30700829
Pubmed	Decreased blood pressure in NOX1-deficient mice.	CACNA1A NOX1	1.92e-05	2	153	2	16386251
Pubmed	Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas.	ARID1A ARID1B	1.92e-05	2	153	2	27562491
Pubmed	Combinatorial CRISPR screen identifies fitness effects of gene paralogues.	RRAS ARID1A ARID1B ZC3H4 RIN2 EPC1 PRKCE	1.96e-05	186	153	7	33637726
Pubmed	Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma.	SOX1 SOX2 ZCCHC9 LAMA3 TFIP11 IDH1 PPP1R13L ITIH1 ZNF638 GAPDHS FYN CNOT1 RSPH10B	2.31e-05	732	153	13	34732716
Pubmed	Integrin expression and integrin-mediated adhesion in vitro of human multipotent stromal cells (MSCs) to endothelial cells from various blood vessels.	ITGA2 ITGA4 ITGAD	2.31e-05	13	153	3	20563599
Pubmed	Pitx3 controls multiple aspects of lens development.	SOX1 SOX2 HSF4	2.93e-05	14	153	3	19334279
Pubmed	Calcium channels link the muscle-derived synapse organizer laminin β2 to Bassoon and CAST/Erc2 to organize presynaptic active zones.	CACNA1A PCLO SV2C	2.93e-05	14	153	3	21228161
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	HSP90B1 ATRX MYO5A PEG10 POLR2B TFIP11 CHD1 PAF1 NCKAP5L SLC5A3 NDC1 UBR5 SLC20A1 VPS13A MRTO4 SAMM50 DIAPH3 SMAP2 PACSIN2	3.10e-05	1487	153	19	33957083
Pubmed	The protein tyrosine kinase family of the human genome.	EPHB6 PDGFRB FRK BMX FYN	3.40e-05	83	153	5	11114734
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	CACNA1A ATRX PCDHGA11 MUC16 CHD7 ITGA2 EPC1 VPS13A TAF1 ABLIM2 HSF4	3.58e-05	552	153	11	10737800
Pubmed	Genetic dissection of plexin signaling in vivo.	MRAS PLXND1 RRAS	3.65e-05	15	153	3	24469813
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	MYO5A PCLO GRIN2D ABLIM1 UBR5 GNA13 PRKCE EVI5L	3.70e-05	281	153	8	28706196
Pubmed	Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells.	MYO5A PSMD4 IDH1 PAF1 ARID1A PRRC2C GNA13 MRTO4 GAPDHS ATP1A2 SNRNP70 CNOT1	4.12e-05	665	153	12	30457570
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	TTC28 MUC16 PLXND1 NDC1 UBR5 ZC3H4 ATF7IP VPS13A ZNF638 SMAP2 GGA1 SDK1 CDON	4.26e-05	777	153	13	35844135
Pubmed	Integrin requirement for hippocampal synaptic plasticity and spatial memory.	ITGA8 ITGA2 ITGA4	4.48e-05	16	153	3	12904471
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	RRAS2 MYO5B AOX1 IDH1 RRAS FRK APPL2 GSTCD SAMM50 PRKCZ SLC4A4 MBD5 PACSIN2 GPRC5B PCYOX1	4.54e-05	1016	153	15	19056867
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	ATRX TTC28 NACC1 CHD1 CHD7 ARID1A ZC3H4 PRRC2C ZNF638 CNOT1	4.66e-05	469	153	10	27634302
Pubmed	A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal.	SOX2 NACC1 POLR2B CHD7 ARID1A CNOT1	4.80e-05	146	153	6	23892456
Pubmed	Fezl is required for the birth and specification of corticospinal motor neurons.	PLXND1 RORB DIAPH3	5.43e-05	17	153	3	16157277
Interaction	RALGDS interactions	RRAS2 MRAS RRAS RIT2 RIT1	6.91e-06	36	151	5	int:RALGDS
Interaction	AFDN interactions	EPHB6 RRAS2 MRAS PPP1R13B PTPRU ITGA4 RRAS RIT2 RIT1 ZNF638 ABLIM2 SDK1	8.18e-06	333	151	12	int:AFDN
Interaction	RGL1 interactions	RRAS2 RIT2 RIT1 LENG8	8.54e-06	18	151	4	int:RGL1
GeneFamily	RAS type GTPase family	RRAS2 MRAS RRAS RIT2 RIT1	1.14e-06	31	110	5	389
GeneFamily	CD molecules\|Integrin alpha subunits	ITGA8 ITGA2 ITGA4 ITGAD	3.72e-06	18	110	4	1160
GeneFamily	Myosins, class V	MYO5A MYO5B	1.10e-04	3	110	2	1100
GeneFamily	Fibronectin type III domain containing	EPHB6 MYOM1 PTPRU ATF7IP SDK1 CDON	4.39e-04	160	110	6	555
Coexpression	LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2	ARHGEF28 TTC28 PCLO FHOD3 ABLIM1 PRRC2C VPS13A SLC4A4 MBD5 SDK1	7.00e-07	221	152	10	M39222
Coexpression	GSE3982_NEUTROPHIL_VS_BASOPHIL_UP	SLC12A6 MYO5A GBP2 CHD1 GFOD2 SLC20A1 SEMA4A SLC4A4 PACSIN2	2.27e-06	196	152	9	M5524
Coexpression	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN	NRAP MYO5A ITGA8 COL6A5 FHOD3 ADAM11 N4BP3 F13A1 NOX1 CIITA ATF7IP GSTCD JOSD1 DHX32 GAPDHS FYN GGA1 SDK1	3.34e-06	873	152	18	M16009
Coexpression	GSE37301_CD4_TCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP	PEG10 CHD7 NCKAP5L APPL2 GFOD2 SLC20A1 SEMA4A PCYOX1	4.94e-06	162	152	8	M8903
Coexpression	LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET	TPST1 HSP90B1 FHOD3 ITGA2 ABLIM1 ARID1B PRKCE MBD5 SDK1	1.17e-05	240	152	9	M39236
Coexpression	HALLMARK_UV_RESPONSE_DN	CACNA1A ATRX PDGFRB PRKCE MMP16 FYN CDON	2.17e-05	144	152	7	M5942
Coexpression	GSE1448_ANTI_VALPHA2_VS_VBETA5_DP_THYMOCYTE_DN	HSP90B1 NPR3 GBP2 ST3GAL2 ARID1A TSPAN33 POLR1E SEMA4A	2.29e-05	200	152	8	M3435
Coexpression	GSE17186_BLOOD_VS_CORD_BLOOD_CD21HIGH_TRANSITIONAL_BCELL_DN	SLC12A6 RRAS2 BTBD8 GBP2 CCDC82 SLC20A1 PRKCZ FYN	2.29e-05	200	152	8	M7186
Coexpression	GSE36078_UNTREATED_VS_AD5_INF_MOUSE_LUNG_DC_DN	RRAS2 CHD7 SLC43A3 ITGA2 GRIN2D BMX ATP1A2 MMP16	2.29e-05	200	152	8	M9292
Coexpression	CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP	MYO5A PDGFRB ITGA8 ITGA2 F13A1 PIEZO2 MMP16	4.62e-05	162	152	7	M45037
Coexpression	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0	AOX1 LAMA3 ABLIM1 RIN2 ATP1A2	6.28e-05	72	152	5	M15699
Coexpression	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0	AOX1 LAMA3 ABLIM1 RIN2 ATP1A2	9.22e-05	78	152	5	MM867
Coexpression	DESCARTES_FETAL_LIVER_MESOTHELIAL_CELLS	EPHB6 MYO5B AOX1 LAMA3 MUC16 PTPRU MTMR7 SLC4A4 CDON	9.28e-05	313	152	9	M40228
Coexpression	BROWNE_HCMV_INFECTION_18HR_DN	EPHB6 CACNA1A PDGFRB PLXND1 RRAS RIN2 FYN	9.62e-05	182	152	7	M6641
Coexpression	DCA_UP.V1_UP	EPHB6 BTBD8 ITGA8 GRIN2D IFIT2 BMX USF2	1.10e-04	186	152	7	M2762
Coexpression	MURARO_PANCREAS_ALPHA_CELL	CACNA1A A1CF PEG10 ZDHHC14 ENAM ABLIM1 MTMR7 GFOD2 RIN2 PRKCE SMAP2 SDK1	1.24e-04	568	152	12	M39168
Coexpression	CUI_TCF21_TARGETS_2_DN	SLC12A6 RRAS2 NPR3 ZDHHC14 ITGA8 PPP1R13B ITGA2 ITGA4 SNX13 FRK CCDC82 RIN2 VPS13A MBD5 FYN	1.39e-04	854	152	15	M1533
Coexpression	DESCARTES_FETAL_SPLEEN_MESOTHELIAL_CELLS	EPHB6 AOX1 MUC16 ITPKC MTMR7 SLC4A4 CDON	1.43e-04	194	152	7	M40292
Coexpression	PEDRIOLI_MIR31_TARGETS_DN	EPHB6 COL17A1 MYOM1 PEG10 PCLO GBP2 PLXND1 IFIT2 GSTCD MMP16	1.56e-04	413	152	10	M2494
Coexpression	GSE20727_CTRL_VS_H2O2_TREATED_DC_UP	CHD7 CR2 B4GALT5 SIDT2 GFOD2 GNA13 GGA1	1.62e-04	198	152	7	M9245
Coexpression	GSE22886_NAIVE_VS_IGG_IGA_MEMORY_BCELL_UP	SLC12A6 TPST1 TTC28 PEG10 AOX1 CR2 SV2C	1.62e-04	198	152	7	M4432
Coexpression	GSE360_L_MAJOR_VS_M_TUBERCULOSIS_DC_UP	RRAS2 GTPBP6 CHD1 BMX SAMM50 USF2 FYN	1.67e-04	199	152	7	M5213
Coexpression	GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN	MYO5A PLXND1 SLC2A4 B4GALT5 PRKCE SLC4A4 EVI5L	1.67e-04	199	152	7	M6519
Coexpression	GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_DN	SLC12A6 CHD1 SLC43A3 CR2 B4GALT5 CIITA SBNO1	1.67e-04	199	152	7	M3186
Coexpression	GSE40443_INDUCED_VS_TOTAL_TREG_UP	EPHB6 ITGA8 ST3GAL2 ADAM11 PLXND1 F13A1 LCMT1	1.67e-04	199	152	7	M9198
Coexpression	GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_BM_UP	SLC12A6 RRAS2 ATRX ARID1A CR2 F13A1 ARID1B	1.72e-04	200	152	7	M8090
Coexpression	GSE24142_ADULT_VS_FETAL_EARLY_THYMIC_PROGENITOR_UP	ZDHHC14 ST3GAL2 RRAS N4BP3 PRKCE PRKCZ GPRC5B	1.72e-04	200	152	7	M4576
Coexpression	GSE27786_CD4_VS_CD8_TCELL_UP	SLC12A6 MYO5A ITGA4 MTMR7 ARID1B CCDC82 SNRNP70	1.72e-04	200	152	7	M4819
Coexpression	GSE42021_CD24HI_VS_CD24INT_TCONV_THYMUS_UP	MRAS NRAP RRAS APPL2 SLC20A1 SLC6A20 JOSD1	1.72e-04	200	152	7	M9591
Coexpression	GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_UP	ARHGEF28 COL17A1 MYO5B PDGFRB TNFRSF17 CR2 BMX	1.72e-04	200	152	7	M8212
Coexpression	GSE14350_IL2RB_KO_VS_WT_TEFF_DN	RRAS2 HSP90B1 GBP2 CHD7 PLXND1 SLC2A4 SV2C	1.72e-04	200	152	7	M3424
Coexpression	GSE17186_BLOOD_VS_CORD_BLOOD_CD21LOW_TRANSITIONAL_BCELL_UP	EPHB6 GBP2 IFIT2 CCDC82 SLC20A1 ATF7IP FYN	1.72e-04	200	152	7	M7195
Coexpression	GSE33424_CD161_HIGH_VS_INT_CD8_TCELL_UP	TPST1 MYO5A CHD1 ITGA4 CIITA PRKCE MRTO4	1.72e-04	200	152	7	M8534
Coexpression	GSE17721_CTRL_VS_LPS_2H_BMDC_DN	RRAS2 ATRX MYO5B CHD1 TSPAN33 GNA13 GAPDHS	1.72e-04	200	152	7	M3688
Coexpression	GSE7831_1H_VS_4H_CPG_STIM_PDC_UP	GLYCTK RRAS BMX RPIA RIN2 EPC1 HSF4	1.72e-04	200	152	7	M6960
Coexpression	BROWNE_HCMV_INFECTION_24HR_DN	RRAS2 PDGFRB ITGA2 N4BP3 RIN2 CDON	2.06e-04	145	152	6	M14098
Coexpression	CUI_TCF21_TARGETS_2_DN	SLC12A6 RRAS2 NPR3 ZDHHC14 ITGA8 PPP1R13B ITGA2 ITGA4 SNX13 FRK CCDC82 RIN2 VPS13A MBD5 FYN	2.12e-04	888	152	15	MM1018
Coexpression	STK33_DN	PLXND1 CR2 F13A1 ABLIM1 SIDT2 BMX RORB PCYOX1	2.39e-04	280	152	8	M2853
Coexpression	SAGIV_CD24_TARGETS_UP	EPHB6 N4BP3 SLC4A4	2.72e-04	22	152	3	M4144
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	ARHGEF28 TTC28 PEG10 ARID1B UBR5 PRRC2C ZNF638 MBD5 SDK1	2.39e-08	193	153	9	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	RRAS2 CHD7 N4BP3 TSPAN33 ARID1B ATF7IP VPS13A PRKCE SMAP2	2.39e-08	193	153	9	bbea475d2c4c7b29674ff302529f8f83dd666dcb
ToppCell	mild-B_naive\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RRAS2 PEG10 CHD7 CR2 TSPAN33 ARID1B CIITA ATF7IP PRKCE	3.25e-08	200	153	9	222789b897e2a683bbfd1d00b6fd8705015d90df
ToppCell	droplet-Lung-3m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MRAS BTBD8 MYOM1 MYO5A NR6A1 CIITA GFOD2 LCMT1	1.09e-07	165	153	8	1d0f60bf47a40ac916f0fcb5532a968742a0edbb
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CACNA1A MYOM1 PDGFRB ITGA8 RRAS PIEZO2 RORB ATP1A2	2.84e-07	187	153	8	ac8e092b37e042975e2ee057d3f7c6821e58e8b5
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CACNA1A MYOM1 PDGFRB ITGA8 RRAS PIEZO2 RORB ATP1A2	2.84e-07	187	153	8	d591a3c216997663ab77710fed0d230ffc37e41a
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CACNA1A MYOM1 PDGFRB ITGA8 RRAS PIEZO2 RORB ATP1A2	2.84e-07	187	153	8	d1dc8c9a2c2cd10c640257161a75e7730ec5bb41
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	RRAS2 CHD7 TSPAN33 ARID1B CIITA ATF7IP PRKCE SMAP2	3.47e-07	192	153	8	446c61c0d6ba89c619efe87ee495951299953981
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	ARHGEF28 TTC28 PEG10 ARID1B UBR5 ZNF638 MBD5 SDK1	3.47e-07	192	153	8	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	IPF-Epithelial-Basal\|World / Disease state, Lineage and Cell class	COL17A1 LAMA3 FHOD3 ITGA2 PTPRU PPP1R13L SLC4A4 SDK1	3.47e-07	192	153	8	9b91e0b162e6f3ce86dd15cc33c2e745d069581f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGEF28 MYO5B PCLO FHOD3 NR6A1 FRK ABLIM1 SLC4A4	3.61e-07	193	153	8	3866667dd221612589ae50f5c52f73a183a49ce6
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGEF28 MYO5B PCLO FHOD3 ITGA2 NR6A1 FRK ABLIM1	3.75e-07	194	153	8	5eaaa81f4b2535f983c424aaef00077089526a5c
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGEF28 MYO5B PCLO FHOD3 ITGA2 NR6A1 ABLIM1 SDK1	3.90e-07	195	153	8	6477e6e7be5bd8eb99119a12ae16334ccddecd43
ToppCell	BAL-Severe-Myeloid-MoAM-MoAM4-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HSP90B1 MRAS MYO5A IDH1 PLXND1 F13A1 ZNF638 USF2	4.72e-07	200	153	8	4f481d87e30195365900acb5d50641a9e7b2f462
ToppCell	Neuronal-Inhibitory-iA\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SOX2 NPR3 ITGA8 LAMA3 GRIN2D RIN2 SV2C SDK1	4.72e-07	200	153	8	5ef4a3dc18a44292184a59ced916183c0699b01e
ToppCell	BAL-Severe-Myeloid-MoAM-MoAM4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HSP90B1 MRAS MYO5A IDH1 PLXND1 F13A1 ZNF638 USF2	4.72e-07	200	153	8	cf720d3973e79ffd4c6e763a7284799ced22a274
ToppCell	Children_(3_yrs)-Immune-dendritic_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NRAP ST3GAL2 ITGA4 TSPAN33 ENAM CIITA GABRR3	1.50e-06	162	153	7	86a0b9dabd150dc993bfc0f3344804de7f8e4042
ToppCell	LV-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	CACNA1A PDGFRB ITGA8 LAMA3 GBP2 FRK PACSIN2	1.70e-06	165	153	7	f37fd95adc95d7753cf6e55ae819976513c7ec77
ToppCell	LV-13._Vascular_Smooth_Muscle\|LV / Chamber and Cluster_Paper	CACNA1A PDGFRB ITGA8 LAMA3 GBP2 FRK PACSIN2	2.15e-06	171	153	7	e99ecae66530d1ae09330cee408c8f3950b87e67
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSP90B1 ATRX PRRC2C ATF7IP RIN2 ZNF638 ATP1A2	2.61e-06	176	153	7	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SOX2 NPR3 ITGA8 GRIN2D SLC6A2 RIN2 SDK1	2.81e-06	178	153	7	3c973aac16988e88f5677d3d695dd772ccfd6570
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SOX1 NPR3 ARHGEF28 ITGA8 LAMA3 CHD7 GRIN2D	2.92e-06	179	153	7	01302505816f272243659e20d751b61a198a2fc0
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SOX1 NPR3 ITGA8 LAMA3 GRIN2D RIN2 SDK1	3.14e-06	181	153	7	35bcdcd2651149692e5b150e887c0f450c81d2d4
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SOX1 NPR3 ITGA8 LAMA3 GRIN2D RIN2 SDK1	3.14e-06	181	153	7	154d5e586cab25155c6d06dfe6ae01203b88e0fb
ToppCell	RA-13._Vascular_Smooth_Muscle\|RA / Chamber and Cluster_Paper	CACNA1A ARHGEF28 PDGFRB ITGA8 LAMA3 SDK1 PACSIN2	3.37e-06	183	153	7	818fd886e0188091310825f9145fa53328f2c979
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NPR3 MRAS SLC43A3 PLXND1 SLC6A2 BMX MMP16	3.37e-06	183	153	7	fc9a7ba148c22d0c8a46f6bc56c772929ac496f7
ToppCell	RA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	CACNA1A ARHGEF28 PDGFRB ITGA8 LAMA3 SDK1 PACSIN2	3.37e-06	183	153	7	cae2ee08f985a6f005b4b8e959e465350315156a
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SOX1 NPR3 ITGA8 LAMA3 GRIN2D RIN2 SDK1	3.50e-06	184	153	7	32473dbdb2de66391157c5814ef34e790806e4f2
ToppCell	Endothelial-E\|World / shred on cell class and cell subclass (v4)	MRAS SLC43A3 PLXND1 SLC6A2 BMX NOX1 MMP16	3.50e-06	184	153	7	b4c561924c508536fd2112e91e32176b95fdf63a
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NPR3 ITGA8 LAMA3 CHD7 GRIN2D RIN2 SDK1	3.62e-06	185	153	7	0b5a0df58ae2ad8261f40f152775747af4f3937a
ToppCell	facs-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPHB6 MYOM1 FHOD3 SLC2A4 SLC4A4 MMP16 GPRC5B	3.76e-06	186	153	7	26458ff8cad5577de4306cffa0ca69eb26940e0d
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARHGEF28 MYO5B LAMA3 ITGA2 NR6A1 FRK PRKCZ	3.76e-06	186	153	7	4e94158db52df41d71e67b02b9895a358eebee0f
ToppCell	facs-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPHB6 MYOM1 FHOD3 SLC2A4 SLC4A4 MMP16 GPRC5B	3.76e-06	186	153	7	a71397efc68d2916ddc373d92cfd07be58033e1c
ToppCell	PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	ARHGEF28 MYO5A MYO5B LAMA3 PPP1R13B ITGA2 PRKCZ	3.89e-06	187	153	7	db2974e2e87ac9f1c2407a371d5ed89af09fc9b7
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CACNA1A MYOM1 PDGFRB ITGA8 PIEZO2 ATP1A2 MMP16	3.89e-06	187	153	7	15d6e158562d7d85af3ceaf955439b379c8fce81
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARHGEF28 MYO5B LAMA3 ITGA2 PPP1R13L FRK PRKCZ	3.89e-06	187	153	7	58d48128547ee3513d0bf7f78e61b76b1c472ca9
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CACNA1A MYOM1 PDGFRB ITGA8 PIEZO2 ATP1A2 MMP16	3.89e-06	187	153	7	f62074b631fd45ad299c69d71b09267b04d656ee
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SOX1 NPR3 ITGA8 LAMA3 GRIN2D RIN2 SDK1	4.03e-06	188	153	7	6ee3f8f94ea7bdf652c9575fc65bff08070093a4
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	RRAS2 PEG10 TSPAN33 ARID1B CIITA ATF7IP SMAP2	4.03e-06	188	153	7	d8decd9b5967873ca8320c2f9f07365f163c777f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CACNA1A MYOM1 PDGFRB ITGA8 PIEZO2 ATP1A2 MMP16	4.03e-06	188	153	7	32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARHGEF28 MYO5B LAMA3 ITGA2 FRK SPHKAP SLC4A4	4.03e-06	188	153	7	4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f
ToppCell	PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	SOX2 MYO5B PCLO LAMA3 PPP1R13B VPS13A PRKCZ	4.03e-06	188	153	7	beb2df2332a46cc81b10e8e29fc9829020111f03
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	SOX2 ARHGEF28 MYO5B PCLO LAMA3 MTMR7 PRKCZ	4.17e-06	189	153	7	7659c7bbd58ee959a159294fb8d17317bbcc5681
ToppCell	IPF-Epithelial-Basal\|IPF / Disease state, Lineage and Cell class	COL17A1 LAMA3 FHOD3 ITGA2 PTPRU PPP1R13L SLC4A4	4.32e-06	190	153	7	ea19e9ce954f2dfde97388db9695325cd92ab88f
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TPST1 PDGFRB AOX1 ITGA8 COL6A5 PIEZO2 SDK1	4.63e-06	192	153	7	ee085e04d5dcfb657522484ed20b8c1ddeccfe0c
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	TTC28 FHOD3 ARID1B PRKCE SLC4A4 MBD5 SDK1	4.63e-06	192	153	7	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NPR3 ITGA8 LAMA3 CHD7 GRIN2D RIN2 SDK1	4.63e-06	192	153	7	6a252e298f8a454623fa9c1c893a7a45a886d694
ToppCell	LPS_only-Stromal_mesenchymal\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TTC28 PDGFRB AOX1 ITGA8 COL6A5 PIEZO2 SDK1	4.63e-06	192	153	7	162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MRAS SLC43A3 PLXND1 SLC6A2 BMX NOX1 MMP16	4.79e-06	193	153	7	58c590dd6f21bc7ae58ae1729dd574c0f1069592
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	RRAS2 CHD7 TSPAN33 ARID1B ATF7IP PRKCE SMAP2	4.79e-06	193	153	7	f4135615ee0118eec9e221becdd67888e0c2a112
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGEF28 MYO5B PCLO FHOD3 NR6A1 ABLIM1 SLC4A4	4.79e-06	193	153	7	82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa
ToppCell	PCW_07-8.5-Epithelial\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	SOX2 ARHGEF28 MYO5B PCLO LAMA3 MTMR7 PRKCZ	4.95e-06	194	153	7	f63ceedb88a9abc8644ee94adfd541e7817c1e3a
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGEF28 MYO5B FHOD3 NR6A1 FRK ABLIM1 SDK1	4.95e-06	194	153	7	7002937e8903e037332a215d00fbc7c7843b33f2
ToppCell	356C-Epithelial_cells-Epithelial-I_(AT1)\|356C / Donor, Lineage, Cell class and subclass (all cells)	MYO5B PEG10 LAMA3 ITGA2 ABLIM1 PRKCZ PCYOX1	5.12e-06	195	153	7	07a3ef6b0f1201fe2bcb9ea426b8f7a69beb4904
ToppCell	356C-Epithelial_cells-Epithelial-I_(AT1)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	MYO5B PEG10 LAMA3 ITGA2 ABLIM1 PRKCZ PCYOX1	5.12e-06	195	153	7	b65511770ed67f7447847e2187555b362988af45
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1A ATRX TTC28 PCLO PRRC2C SPHKAP VPS13A	5.12e-06	195	153	7	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1A ATRX TTC28 PCLO PRRC2C SPHKAP VPS13A	5.12e-06	195	153	7	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	facs-Aorta-Heart-3m-Endothelial-aorta_endothelial_cell\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NPR3 LAMA3 PLXND1 PTPRU PIEZO2 RIN2 FYN	5.12e-06	195	153	7	3969b8d5fcec8ef1831531a781f7bbcebab5a4ba
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MYO5A ITGA4 F13A1 CIITA GNA13 FYN SMAP2	5.48e-06	197	153	7	c9b1f2ee7eb31a66af331c5aae29e1bbb5186f5a
ToppCell	COVID-19_Severe-B_naive\|COVID-19_Severe / disease group, cell group and cell class	RRAS2 PEG10 CHD7 CR2 CIITA ATF7IP SMAP2	5.48e-06	197	153	7	b8f18b39435e2229ba3bc07a25eb875d1ec11f6f
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / Treatment groups by lineage, cell group, cell type	ARHGEF28 SLC43A3 ITGA2 PTPRU SLC6A20 JOSD1 SLC4A4	5.48e-06	197	153	7	1a1bee8da6e04b65935c40373eaee4d6c046d9a1
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYO5B LAMA3 PPP1R13B NR6A1 PRKCZ SLC4A4 PACSIN2	5.85e-06	199	153	7	8587bd98de7767a575088afbea07a1feb4516b9b
ToppCell	Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SOX1 SOX2 ITGA8 SPHKAP SV2C SDK1 GPRC5B	6.05e-06	200	153	7	ca5401b76ab014080914bf78042d368cf318effa
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-B-B_naive\|COVID-19_Severe / Disease, condition lineage and cell class	RRAS2 PEG10 CHD7 CR2 TSPAN33 CIITA ATF7IP	6.05e-06	200	153	7	5ba9c541fa356d34f392a63274dcd7bfb844cbb6
ToppCell	Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CBLN1-L2-4\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SOX2 NPR3 ITGA8 LAMA3 CHD7 RIN2 SDK1	6.05e-06	200	153	7	2086024ce808b8796ed508a229b098eb02f8828a
ToppCell	Severe_COVID-19-Myeloid-MoAM4\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	MRAS MYO5A IDH1 PLXND1 F13A1 ZNF638 USF2	6.05e-06	200	153	7	30448a41ca64d6f0fedaff0b7a6670dd33cdf2c5
ToppCell	Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3\|Neuronal / cells hierarchy compared to all cells using T-Statistic	NPR3 ITGA8 LAMA3 CHD7 GRIN2D RIN2 SDK1	6.05e-06	200	153	7	7e51715525fdb001b7042b2bfcb9de81ecb5e4ee
ToppCell	Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1--L2-6\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SOX1 SOX2 ITGA8 SPHKAP SV2C SDK1 GPRC5B	6.05e-06	200	153	7	70c47d3bbe67d88c5b9dff99c33a603d25fa2ab0
ToppCell	Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CBLN1\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SOX2 NPR3 ITGA8 LAMA3 CHD7 RIN2 SDK1	6.05e-06	200	153	7	35951db6a4f442ac9e13f1b8cc5b4a33481f92c8
ToppCell	Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SOX1 SOX2 ITGA8 SPHKAP SV2C SDK1 GPRC5B	6.05e-06	200	153	7	40286010bd17cf9e34ecd5440953b072ebfae208
ToppCell	severe-B_naive\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RRAS2 PEG10 CHD7 TSPAN33 CIITA ATF7IP SMAP2	6.05e-06	200	153	7	0e86f52b6e146d9bbc728d8fb176fc2b53696558
ToppCell	Biopsy_Other_PF-Epithelial-Basal\|Biopsy_Other_PF / Sample group, Lineage and Cell type	SOX2 COL17A1 LAMA3 FHOD3 ITGA2 PPP1R13L SLC4A4	6.05e-06	200	153	7	7098ae4b0ea8ba607519eaed8577c577530fc2a1
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / Treatment groups by lineage, cell group, cell type	MYO5B LAMA3 CHD7 ITGA2 PTPRU SLC6A20 SNRNP70	6.05e-06	200	153	7	2dadf317a42a7e27cc1fac74f91b806c93a57108
ToppCell	BAL-Severe-Myeloid-MoAM-MoAM4-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MRAS MYO5A IDH1 PLXND1 F13A1 ZNF638 USF2	6.05e-06	200	153	7	5490393c5f54748f912676e19b58bd1320415a06
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	HSP90B1 CHD1 ARID1B PRRC2C EPC1 SMAP2 CNOT1	6.05e-06	200	153	7	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	COVID-19-Myeloid-MoAM2,_CCL18\|Myeloid / Condition, Lineage and Cell class	HSP90B1 MYO5A IDH1 PLXND1 F13A1 USF2 GGA1	6.05e-06	200	153	7	a60346c5ea7a3dae1ad3c5dc6c6eca65b64c6888
ToppCell	severe-B_naive\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RRAS2 PEG10 CR2 TSPAN33 CIITA ATF7IP SMAP2	6.05e-06	200	153	7	306df1f498ac2188eaf9f2a8d002bb73bdb9642d
ToppCell	BAL-Severe-Myeloid-MoAM-MoAM4\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	MRAS MYO5A IDH1 PLXND1 F13A1 ZNF638 USF2	6.05e-06	200	153	7	df821ac12953e44fcfedbbefb35a4976e406ccd6
ToppCell	Neuronal-Inhibitory-iA-iA_3(VIP)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	NPR3 ITGA8 LAMA3 CHD7 GRIN2D RIN2 SDK1	6.05e-06	200	153	7	75649534a98bc738fca62d071de0978dc61eb24f
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYOM1 PDGFRB ITGA8 PIEZO2 ATP1A2 MMP16	1.86e-05	159	153	6	5ca96db4281abb5f646150ccf36adc66ab201c78
ToppCell	RV-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	CACNA1A PDGFRB ITGA8 LAMA3 SDK1 PACSIN2	1.93e-05	160	153	6	29c9b4770d0e73d59cffc7937b179484c76b6dcc
ToppCell	BAL-Mild-cDC_5\|Mild / Compartment, Disease Groups and Clusters	MUC16 PPP1R13B NPHP4 SLC5A3 RSPH10B2 ITPKC	2.00e-05	161	153	6	7a6e8ed0b5d999efce8945d8083ab01d71be9a92
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MRAS SLC43A3 ADAM11 SLC6A2 NOX1 MMP16	2.00e-05	161	153	6	f4f5d6eaa32169de699c8ff8e8ae35179c8e25c0
ToppCell	droplet-Liver-LIVER_HEP-30m-Myeloid-macrophage/monocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC12A6 ITGA4 ITGAD BMX CIITA DIAPH3	2.07e-05	162	153	6	93bd29c52846c3156b8b0d2e39c552373efdfe93
ToppCell	facs-Lung-nan-3m-Epithelial-type_I_pneumocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGEF28 LAMA3 PPP1R13B GRIN2D SLC6A20 PRKCZ	2.38e-05	166	153	6	11b0ae82b3068ef91715dbdd49fe8e9791b4a480
ToppCell	facs-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_1\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGEF28 LAMA3 PPP1R13B GRIN2D SLC6A20 PRKCZ	2.38e-05	166	153	6	fcc1aec31ebd39432d4cb284dc8fadf34e3c566a
ToppCell	facs-Thymus-nan-3m-Myeloid\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO5A ADAM11 ITGA4 CR2 TSPAN33 CIITA	2.54e-05	168	153	6	d2afc097ae1243574210be6a751685f949ea941a
ToppCell	facs-Thymus-nan-3m-Myeloid-macrophage\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO5A ADAM11 ITGA4 CR2 TSPAN33 CIITA	2.54e-05	168	153	6	d72cd8238fa793bb3e4add4c59eaaaadcea9930d
ToppCell	facs-Thymus-nan-3m-Myeloid-macrophage\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO5A ADAM11 ITGA4 CR2 TSPAN33 CIITA	2.54e-05	168	153	6	c34c52165485f612add7a3e35a175d5a6e365e7c
ToppCell	AT1-AT2_cells-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	PEG10 PCLO LAMA3 ABLIM1 PRKCZ PCYOX1	2.63e-05	169	153	6	815474855a70498a74e52f6583113c63b7267a0c
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MRAS GBP2 SLC43A3 SLC6A2 BMX MMP16	2.63e-05	169	153	6	04c6ed38e1d1befba5ef5f37a3c1e045a0b163d6
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MRAS GBP2 SLC43A3 SLC6A2 BMX MMP16	2.63e-05	169	153	6	58136b8a0bf2dab45c91a053ef7225ea49ccb871
ToppCell	facs-Lung-nan-3m-Endothelial-vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MRAS NRAP PTPRU SLC6A2 NOX1 MMP16	2.72e-05	170	153	6	67d7e1da3ebd2d14cb2e67799e94d655027ed5c4
ToppCell	ASK428-Epithelial-Secretory\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	SOX2 EPHB6 ZCCHC9 PEG10 NCKAP5L PRTFDC1	2.72e-05	170	153	6	9e275c4a70f9866f770fbdb0fe14a577287fe290
ToppCell	facs-Lung-nan-3m-Endothelial-Vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MRAS NRAP PTPRU SLC6A2 NOX1 MMP16	2.72e-05	170	153	6	8e1f757ed62218c0fb6525f49d142dd2cd29acf9
ToppCell	facs-Marrow-B-cells-18m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL17A1 PLXND1 RRAS F13A1 SLC6A20 DIAPH3	2.72e-05	170	153	6	6e82e41acd1299aa549a32ac036b39754abdf376
ToppCell	COVID-19-Heart-CM_+_Macrophage\|Heart / Disease (COVID-19 only), tissue and cell type	NRAP MYOM1 MYO5A FHOD3 IDH1 F13A1	2.72e-05	170	153	6	4232fe937909f93d3736988c707b8f95ce993398
ToppCell	10x5'v1-week_17-19-Hematopoietic-HSC/MPP_and_pro-ELP\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	PDGFRB AOX1 ITGA4 ITGAD ENAM RORB	2.72e-05	170	153	6	a50e558d0b38100ccbdccb90647fe93e85bffd86
ToppCell	facs-Marrow-B-cells-18m-Myeloid-monocyte_+_promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL17A1 PLXND1 RRAS F13A1 SLC6A20 DIAPH3	2.72e-05	170	153	6	18cd941bf3ca7cc0b6af1317bd2619d283353de0
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYOM1 PDGFRB ITGA8 PIEZO2 ATP1A2 MMP16	2.72e-05	170	153	6	876b84740e15399bfff2b9c7f0b80fd759bbdb3f
Drug	losartan	COL17A1 ITGA8 ITGA2 ITGA4 PAF1 ITGAD SLC6A2 NOX1 PRKCE PRKCZ ATP1A2 SLC4A4 MMP16	1.75e-06	378	153	13	CID000003961
Drug	Ampyrone [83-07-8]; Down 200; 19.6uM; MCF7; HT_HG-U133A	SLC12A6 A1CF ARID1A SNX13 SLC5A3 FRK RIN2 VPS13A MMP16	7.11e-06	195	153	9	6845_DN
Drug	magnesium	RRAS2 HSP90B1 NPR3 GTPBP6 MYO5A MYO5B POLR2B LAMA3 IDH1 ITGA2 GRIN2D RRAS CPT1B TNFRSF17 ITGAD PRTFDC1 RIT2 POLI PRKCE PRKCZ ATP1A2 TRMT5 MMP16 FYN	8.62e-06	1325	153	24	CID000000888
Drug	sulcofuron	RRAS2 MYO5A RRAS	1.02e-05	7	153	3	CID000062506
Drug	nitric oxide	SLC12A6 NPR3 PDGFRB PEG10 ITGA8 IDH1 ITGA2 GRIN2D ITGA4 PAF1 ITGAD SLC2A4 RIT2 BMX NOX1 GSTCD PRKCE PRKCZ GAPDHS ATP1A2 MMP16	1.09e-05	1075	153	21	CID000145068
Drug	K-Cl	EPHB6 CACNA1A SLC12A6 NPR3 MYO5A MYO5B PEG10 CPT1B PAF1 RIT2 POLI GAPDHS ATP1A2 HSF2	3.02e-05	567	153	14	CID000004873
Drug	kalinin	COL17A1 LAMA3 ITGA2 ITGA4 USF2	3.41e-05	55	153	5	CID000032518
Drug	Ampyrone [83-07-8]; Down 200; 19.6uM; PC3; HT_HG-U133A	ATRX TFIP11 SNX13 SBNO1 PRRC2C GSTCD TAF1 SLC4A4	4.48e-05	190	153	8	4507_DN
Drug	benoxacor	GSTCD SLC4A4	4.49e-05	2	153	2	CID000062306
Drug	St-608	PEG10 PAF1	4.49e-05	2	153	2	CID000028098
Drug	tolonidine	PEG10 PAF1	4.49e-05	2	153	2	CID000072138
Drug	H 297	GSTCD SLC4A4	4.49e-05	2	153	2	CID000033097
Drug	Ald1.1-H_000455; Up 200; 10uM; PC3; HT_HG-U133A	CPT1B ARID1A SNX13 SLC5A3 PIEZO2 GFOD2 SEMA4A GGA1	4.65e-05	191	153	8	7547_UP
Drug	CH-38083	NPR3 PAF1 SLC6A2	4.72e-05	11	153	3	CID000123716
Drug	1,4-dinitrobenzene	PDGFRB ITGA2 GSTCD	4.72e-05	11	153	3	CID000007492
Drug	Metaraminol bitartrate [33402-03-8]; Up 200; 8.6uM; PC3; HT_HG-U133A	PLXND1 NR6A1 F13A1 SLC2A4 NOX1 PRKCE RORB HSF2	5.38e-05	195	153	8	3669_UP
Drug	(2s,5s)-5-Carboxymethylproline	SOX2 RRAS2 COL17A1 PDGFRB ITGA8 GBP2 ST3GAL2 ITGA2 ITGA4 ITGAD	5.44e-05	314	153	10	CID000447989
Drug	(S)-propranolol hydrochloride [4199-10-4]; Up 200; 13.6uM; HL60; HT_HG-U133A	CACNA1A PEG10 NR6A1 ARID1A ITPKC NOX1 SLC4A4 GGA1	5.58e-05	196	153	8	2961_UP
Drug	Isopropamide iodide [71-81-8]; Up 200; 8.4uM; MCF7; HT_HG-U133A	A1CF ATRX TTC28 ZDHHC14 ST3GAL2 NR6A1 CPT1B SNX13	5.58e-05	196	153	8	3461_UP
Drug	Oleandomycin phosphate [7060-74-4]; Down 200; 5uM; MCF7; HT_HG-U133A	ATRX AOX1 GBP2 ITGA2 ABLIM1 TAF1 SLC4A4 MMP16	5.78e-05	197	153	8	1518_DN
Drug	Pyridoxine hydrochloride [58-56-0]; Up 200; 19.4uM; MCF7; HT_HG-U133A	SLC12A6 AOX1 ZDHHC14 ITGA2 NR6A1 CPT1B PRKCE CDON	5.78e-05	197	153	8	2751_UP
Drug	thioridazine hydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A	PCLO NR6A1 SLC6A20 ELAVL3 SLC4A4 MMP16 FYN GPRC5B	5.99e-05	198	153	8	5916_DN
Drug	Metronidazole [443-48-1]; Down 200; 23.4uM; MCF7; HT_HG-U133A	SLC12A6 ST3GAL2 PLXND1 NOX1 GSTCD PRKCE USF2 GGA1	5.99e-05	198	153	8	1503_DN
Disease	LEOPARD Syndrome	MRAS RRAS PPP1R13L RIT1	4.03e-06	22	147	4	C0175704
Disease	immature granulocyte measurement	CHD7 ITGA4 PRTFDC1	4.18e-06	7	147	3	EFO_0803543
Disease	Noonan Syndrome	RRAS2 MRAS RRAS RIT1	5.81e-06	24	147	4	C0028326
Disease	epilepsy and migraine	CACNA1A ATP1A2	2.47e-05	2	147	2	C0270816
Disease	Bipolar Disorder	CACNA1A SLC12A6 HSP90B1 PCLO ITIH1 SLC5A3 SLC6A2 PRKCZ ATP1A2 MBD5 FYN	2.89e-05	477	147	11	C0005586
Disease	Prostatic Neoplasms	SOX2 HSP90B1 NPR3 AOX1 CHD1 CHD7 IDH1 RRAS ARID1A APPL2 GSTCD PRKCZ	6.39e-05	616	147	12	C0033578
Disease	Malignant neoplasm of prostate	SOX2 HSP90B1 NPR3 AOX1 CHD1 CHD7 IDH1 RRAS ARID1A APPL2 GSTCD PRKCZ	6.39e-05	616	147	12	C0376358
Disease	Familial or sporadic hemiplegic migraine	CACNA1A ATP1A2	7.37e-05	3	147	2	cv:CN295307
Disease	Costello syndrome (implicated_via_orthology)	RRAS2 RRAS	7.37e-05	3	147	2	DOID:0050469 (implicated_via_orthology)
Disease	Familial hemiplegic migraine	CACNA1A ATP1A2	7.37e-05	3	147	2	cv:C0338484
Disease	Noonan-Like Syndrome With Loose Anagen Hair	MRAS RRAS RIT1	1.11e-04	19	147	3	C3501846
Disease	Noonan syndrome-like disorder with loose anagen hair	MRAS RRAS RIT1	1.11e-04	19	147	3	C1843181
Disease	Cardio-facio-cutaneous syndrome	MRAS RRAS RIT1	1.11e-04	19	147	3	C1275081
Disease	Costello syndrome (disorder)	MRAS RRAS RIT1	1.11e-04	19	147	3	C0587248
Disease	Alternating hemiplegia of childhood	CACNA1A ATP1A2	1.47e-04	4	147	2	C0338488
Disease	Adult junctional epidermolysis bullosa (disorder)	COL17A1 LAMA3	2.44e-04	5	147	2	C0268374
Disease	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, LOCALISATA VARIANT (disorder)	COL17A1 LAMA3	2.44e-04	5	147	2	C2608084
Disease	MENTAL RETARDATION, AUTOSOMAL DOMINANT 12	ARID1A ARID1B	2.44e-04	5	147	2	C3281201
Disease	junctional epidermolysis bullosa non-Herlitz type (implicated_via_orthology)	COL17A1 LAMA3	2.44e-04	5	147	2	DOID:0060738 (implicated_via_orthology)
Disease	non-high density lipoprotein cholesterol measurement	CACNA1A A1CF NACC1 CHD7 ARID1A ENAM FRK NDC1 APPL2 SBNO1 ZC3H4 PRKCE	2.49e-04	713	147	12	EFO_0005689
Disease	Junctional Epidermolysis Bullosa	COL17A1 LAMA3	3.65e-04	6	147	2	C0079301
Disease	migraine with aura (is_implicated_in)	CACNA1A ATP1A2	3.65e-04	6	147	2	DOID:10024 (is_implicated_in)
Disease	familial hemiplegic migraine (implicated_via_orthology)	CACNA1A ATP1A2	5.09e-04	7	147	2	DOID:0060178 (implicated_via_orthology)
Disease	junctional epidermolysis bullosa (is_implicated_in)	COL17A1 LAMA3	5.09e-04	7	147	2	DOID:3209 (is_implicated_in)
Disease	Amelogenesis imperfecta local hypoplastic form	LAMA3 ENAM	5.09e-04	7	147	2	C0399367
Disease	sensory perception of taste	FRK ABLIM1 MMP16	5.92e-04	33	147	3	GO_0050909
Disease	mean platelet volume	SLC12A6 TTC28 MYO5A PCDHGA11 ZDHHC14 CHD7 ITGA2 PLXND1 SNX13 PCDHGA12 EPC1 SV2C SMAP2 PACSIN2	5.99e-04	1020	147	14	EFO_0004584
Disease	cerebellar ataxia (implicated_via_orthology)	CACNA1A VPS13A	6.77e-04	8	147	2	DOID:0050753 (implicated_via_orthology)
Disease	RASopathy (implicated_via_orthology)	RRAS2 RRAS	8.67e-04	9	147	2	DOID:0080690 (implicated_via_orthology)
Disease	urinary bladder cancer (implicated_via_orthology)	RRAS2 RRAS	8.67e-04	9	147	2	DOID:11054 (implicated_via_orthology)
Disease	autism spectrum disorder (implicated_via_orthology)	PDGFRB CHD1 CHD7 SLC6A2 ARID1B	1.01e-03	152	147	5	DOID:0060041 (implicated_via_orthology)
Disease	neuroblastoma (is_implicated_in)	ARID1A ARID1B	1.08e-03	10	147	2	DOID:769 (is_implicated_in)
Disease	Parkinson disease	ITGA8 ITIH1 RIT2 CCDC82 SV2C SEMA4A FYN	1.17e-03	321	147	7	MONDO_0005180
Disease	Pancreatic Ductal Adenocarcinoma	ADAM11 ABLIM2	1.32e-03	11	147	2	C1335302
Disease	quality of life during menstruation measurement, acne	FHOD3 SDK1	1.32e-03	11	147	2	EFO_0003894, EFO_0009366
Disease	ovarian serous carcinoma	TTC28 LAMA3 FYN	1.57e-03	46	147	3	EFO_1001516
Disease	Amelogenesis Imperfecta	COL17A1 ENAM	1.57e-03	12	147	2	C0002452
Disease	Neuroblastoma	ATRX ARID1A ARID1B	1.67e-03	47	147	3	C0027819
Disease	schizophrenia, anorexia nervosa	ACTR5 PPP1R13B MMP16	1.78e-03	48	147	3	MONDO_0005090, MONDO_0005351
Disease	salicylurate measurement	ABLIM1 ZNF638	1.85e-03	13	147	2	EFO_0010532
Disease	Coffin-Siris syndrome	ARID1A ARID1B	1.85e-03	13	147	2	C0265338
Disease	vitamin D measurement, COVID-19	RRAS2 SLC6A20 SLC4A4	1.89e-03	49	147	3	EFO_0004631, MONDO_0100096
Disease	developmental disorder of mental health (implicated_via_orthology)	PLXND1 GRIN2D GABRR3	1.89e-03	49	147	3	DOID:0060037 (implicated_via_orthology)
Disease	osteoprotegerin measurement	ARID1A SAMM50	2.16e-03	14	147	2	EFO_0005918
Disease	5-methyluridine (ribothymidine) measurement	PCLO CPT1B	2.16e-03	14	147	2	EFO_0020013
Disease	African Burkitt's lymphoma	ARID1A GNA13	2.48e-03	15	147	2	C0343640
Disease	Burkitt Leukemia	ARID1A GNA13	2.48e-03	15	147	2	C4721444
Disease	Peripheral Nervous System Diseases	SLC12A6 MYO5A PRKCE	2.49e-03	54	147	3	C4721453
Disease	Drug habituation	FHOD3 ABLIM1 APPL2 PRKCE	2.66e-03	115	147	4	C0013170
Disease	Drug abuse	FHOD3 ABLIM1 APPL2 PRKCE	2.66e-03	115	147	4	C0013146
Disease	Prescription Drug Abuse	FHOD3 ABLIM1 APPL2 PRKCE	2.66e-03	115	147	4	C4316881
Disease	Substance-Related Disorders	FHOD3 ABLIM1 APPL2 PRKCE	2.66e-03	115	147	4	C0236969
Disease	Drug Use Disorders	FHOD3 ABLIM1 APPL2 PRKCE	2.66e-03	115	147	4	C0013222
Disease	Drug Dependence	FHOD3 ABLIM1 APPL2 PRKCE	2.66e-03	115	147	4	C1510472
Disease	Substance Dependence	FHOD3 ABLIM1 APPL2 PRKCE	2.66e-03	115	147	4	C0038580
Disease	Substance Use Disorders	FHOD3 ABLIM1 APPL2 PRKCE	2.66e-03	115	147	4	C0038586
Disease	Organic Mental Disorders, Substance-Induced	FHOD3 ABLIM1 APPL2 PRKCE	2.66e-03	115	147	4	C0029231
Disease	Substance abuse problem	FHOD3 ABLIM1 APPL2 PRKCE	2.75e-03	116	147	4	C0740858
Disease	Tremor, Rubral	SOX2 CACNA1A	2.83e-03	16	147	2	C0750940
Disease	Ataxia, Appendicular	SOX2 CACNA1A	2.83e-03	16	147	2	C0750937
Disease	Ataxia, Motor	SOX2 CACNA1A	2.83e-03	16	147	2	C0278161
Disease	Ataxia, Sensory	SOX2 CACNA1A	2.83e-03	16	147	2	C0240991
Disease	Abnormal coordination	SOX2 CACNA1A	2.83e-03	16	147	2	C0520966
Disease	autism spectrum disorder (is_implicated_in)	ITGA4 MBD5	2.83e-03	16	147	2	DOID:0060041 (is_implicated_in)
Disease	Ataxia, Truncal	SOX2 CACNA1A	2.83e-03	16	147	2	C0427190
Disease	pyroglutamine measurement	MYO5A PRTFDC1 SLC6A20	3.06e-03	58	147	3	EFO_0005408
Disease	response to citalopram, antidepressant-induced dizziness, response to buspirone, response to antidepressant	ZDHHC14 GGA1	3.19e-03	17	147	2	EFO_0006321, EFO_0006329, EFO_0006330, GO_0036276
Disease	Astrocytosis	ITGA2 ITGA4	3.19e-03	17	147	2	C3887640
Disease	immature granulocyte count	ITGA4 PRTFDC1	3.19e-03	17	147	2	EFO_0803542
Disease	Gliosis	ITGA2 ITGA4	3.19e-03	17	147	2	C0017639
Disease	adverse effect, response to xenobiotic stimulus	FHOD3 RIT2 USF2	3.21e-03	59	147	3	EFO_0009658, GO_0009410
Disease	apolipoprotein A 1 measurement	ARHGEF28 MYO5B PTPRU ARID1A ITIH1 SNX13 RIT2 FRK SBNO1 ZC3H4 CNOT1	3.57e-03	848	147	11	EFO_0004614
Disease	chromosomal aberration frequency	RRAS2 UBR5	3.58e-03	18	147	2	EFO_0009860
Disease	systemic lupus erythematosus (is_implicated_in)	CR2 CIITA SNRNP70	3.70e-03	62	147	3	DOID:9074 (is_implicated_in)
Disease	alcohol consumption measurement	CACNA1A PCLO ZDHHC14 PPP1R13B NR6A1 ITGA4 B4GALT5 RIT2 ZC3H4 SPHKAP ABLIM2 SNRNP70 SDK1 GPRC5B	3.74e-03	1242	147	14	EFO_0007878
Disease	Juvenile Myelomonocytic Leukemia	RRAS2 RRAS	3.99e-03	19	147	2	C0349639
Disease	cholangiocarcinoma (is_marker_for)	SOX2 MUC16 SLC4A4	4.04e-03	64	147	3	DOID:4947 (is_marker_for)
Disease	coagulation factor measurement	CFHR5 F13A1	4.42e-03	20	147	2	EFO_0004634
Disease	ovarian neoplasm	RRAS2 ITGA8 MUC16 PRTFDC1	4.60e-03	134	147	4	C0919267
Disease	platelet component distribution width	ZDHHC14 SLC43A3 ITGA2 PRTFDC1 SIDT2 PRRC2C RIN2 EPC1 SMAP2 PACSIN2	4.67e-03	755	147	10	EFO_0007984
Disease	Malignant neoplasm of ovary	RRAS2 ITGA8 MUC16 PRTFDC1	4.98e-03	137	147	4	C1140680

Protein segments in the cluster

Peptide	Gene	Start	Entry
NRAIETMYNQCMEVG	TPST1	216	O60507
NSQSVEMREMGRDGY	CACNA1A	2061	O00555
SESMQRQGLLQGMAY	COL17A1	1381	Q9UMD9
QLDMEGMSQYFQRVI	EVI5L	321	Q96CN4
GDYNGEIMSEVMAQR	EPC1	276	Q9H2F5
QMFTEGEEMYLQGST	ABLIM1	316	O14639
RMMMDFNGNNRGYAF	A1CF	86	Q9NQ94
LSGFSMEQAQAYVMR	CIITA	566	P33076
EGAFMVRNSSQVGMY	BMX	316	P51813
GVNEYGNMGAMAVTL	ADAM11	356	O75078
MSQKEMEQLFSQYGR	ELAVL3	136	Q14576
CGQMFAEGEEMYLQG	ABLIM2	241	Q6H8Q1
GFMAGTQRNPQMAQY	ARID1B	861	Q8NFD5
MLVQNVFLTGGNTMY	ACTR5	486	Q9H9F9
MGNYMNAGSRNAQTF	DIAPH3	846	Q9NSV4
MQIARDVDGSGNYLM	DHX32	626	Q7L7V1
PGIVNTYLFMMQAQG	B4GALT5	36	O43286
SYMARGDFSMQQHGQ	CHD7	191	Q9P2D1
MNAVVYLGDINSRNM	CHD1	556	O14646
MRGQVDYSKIMNGNL	PPP1R13B	196	Q96KQ4
QGLNMEDYVNMFVEG	NPR3	346	P17342
GGQEHFYMETQSMLV	AOX1	746	Q06278
QEEFSAMREQYMRTG	MRAS	71	O14807
SYRNDQSMGEMQIIG	PRTFDC1	111	Q9NRG1
YYGMVLQDGQTFNQM	ITPKC	456	Q96DU7
DEGINGEVMYSFRNM	PCDHGA11	271	Q9Y5H2
ESGFYQMEVQAMDNA	PCDHGA12	311	O60330
QMEVQAMDNAGYSAR	PCDHGA12	316	O60330
QPVTMIFMGYQNIED	PALM2	276	Q8IXS6
MLNGGDEVYANCMVI	ARHGEF28	366	Q8N1W1
MNQSSIAQDRGYMQR	ARID1A	741	O14497
QMNKRGFSMEVGQYI	NOX1	311	Q9Y5S8
DGSMYEGEVVNGMRN	RSPH10B	151	P0C881
DGSMYEGEVVNGMRN	RSPH10B2	151	B2RC85
TINNLRYMADMGQPG	MUC16	13931	Q8WXI7
RENGGTENMFVMYLG	LAMA3	2426	Q16787
AGMYQGADTFMQQLL	NCKAP5L	1016	Q9HCH0
VMSMENNGRAQRIYE	ITIH1	446	P19827
NYQNHMRGRYEGVGM	NRAP	411	Q86VF7
SRYIMGSGESFMQLQ	GTPBP6	246	O43824
SGMYNRFEKGMQPRQ	MTMR7	501	Q9Y216
NFIIGMGFQYVAEAM	SLC2A4	431	P14672
MEYVNGGDLMFQIQR	PRKCE	486	Q02156
QYSMVAGAGRENGME	LENG8	16	Q96PV6
GAKVRGQYDDMGENM	PCLO	3416	Q9Y6V0
VGGRLATMMVQGQEY	PCYOX1	71	Q9UHG3
ATMMVQGQEYEAGGS	PCYOX1	76	Q9UHG3
SGMEMACDYGNNIRT	PLXND1	631	Q9Y4D7
QGMGSVIDYSNAFQM	PEG10	176	Q86TG7
YVMDRAQMDLSGRGN	F13A1	241	P00488
FVYNSMGTINQQAMD	GBP2	126	P32456
MGDQTYNEMGDVDQF	GGA1	616	Q9UJY5
MLGNGNYDVNVIMAA	JOSD1	76	Q15040
MAAQGMVETRVFLQY	GNA13	131	Q14344
GDNFQMEMSQVGFSA	ITGA2	371	P17301
MTFIQNFTGEQMASY	ITGA8	306	P53708
YEQDNMVVSGDMLGF	NPHP4	791	O75161
GRQQYGLMEVEFMSG	PTPRU	1296	Q92729
MTMYLFGNVKLQQGD	GPRC5B	251	Q9NZH0
NMSQENVDMRDSYLG	ITGAD	391	Q13349
GNMERIMKAQAYQTG	HSP90B1	656	P14625
DQGTPQYMENMEQVF	PACSIN2	216	Q9UNF0
IRGMMDEEGNQFVAY	PAF1	246	Q8N7H5
GMTGAQVIQMLAQNY	FRK	436	P42685
GELYNTRTMQIDNFM	CCDC82	441	Q8N4S0
MQDAFQNAYMELGGL	ATP1A2	531	P50993
YQQIDMRGMYQPVAG	ATRX	2451	P46100
RMYNIDAVQAMAFDG	GABRR3	371	A8MPY1
NFEEGGGVAMGMYNQ	IDH1	171	O75874
TGMMAENFLYGNEVS	CR2	731	P20023
AMQGDVKSMAQFYGL	GLYCTK	336	Q8IVS8
AAQVAAGMAYIERMN	FYN	371	P06241
NVGQILNMADMYGLE	BTBD8	276	Q5XKL5
RMKIGMAQFGSNYQS	COL6A5	1041	A8TX70
LYQGSDMNGQMVDYT	CDON	1006	Q4KMG0
DMNGQMVDYTTLSGA	CDON	1011	Q4KMG0
MLYVDGMNGVINRNE	FHOD3	176	Q2V2M9
GMVYMVQALRQSFQG	GFOD2	306	Q3B7J2
LQAMQRVYGAQNEMC	APPL2	41	Q8NEU8
NCRNEYAMIGNNMIT	CFHR5	296	Q9BXR6
NMSYRNAGTVRQMLE	ATF7IP	686	Q6VMQ6
SNMASFVRQLNMYGF	HSF4	66	Q9ULV5
MIGSSNAMGRLYVQE	MBD5	171	Q9P267
FQVMNLRENGMYGKR	IFIT2	296	P09913
VYINSGSGAVMNAME	ITGA4	341	P13612
GENLNYGMQITRMNS	ENAM	826	Q9NRM1
MFVMGVNENDYNPGS	GAPDHS	201	O14556
GSQIAAEMREAMYNQ	POLI	201	Q9UNA4
QIAYAMQMSLQGAEF	PSMD4	286	P55036
SYNTMVGNNEGSMVL	SAMM50	131	Q9Y512
SAAMLNNMRVYGTAF	SLC12A6	311	Q9UHW9
MEYELQMQAFNAVGA	SDK1	1246	Q7Z5N4
DVEMYNSTQGLLMAG	SLC20A1	91	Q8WUM9
ATGASEPRNMAYMNR	SBNO1	476	A3KN83
IQANMEYFTGMFNIG	GSTCD	496	Q8NEC7
VEQSMGLMNSGAVYA	PPP1R13L	751	Q8WUF5
QNMYRLAMTGAGIDR	CPT1B	641	Q92523
GLNYRDGVMQAMDEF	FAM166A	231	Q6J272
YMWDSQSGRFQQMGD	MRTO4	206	Q9UKD2
MDLVGFSYQVANGME	PDGFRB	801	P09619
NNMASFVRQLNMYGF	HSF2	56	Q03933
NMIKVYNQFMGGVDR	PGBD3	451	Q8N328
YQEVPATEEGMMGNF	NTMT2	76	Q5VVY1
SVELNGFMAFREQYM	NR6A1	201	Q15406
SGQMEVYDAELFNMQ	POLR1E	96	Q9GZS1
AERVYFGMQDGSVNM	RPIA	291	P49247
NGLEGLGNDSRDMYM	SNRNP70	401	P08621
YGVDRFSNDIQQMMG	SLC6A2	496	P23975
NVALQFFMDYMQQTG	SNX13	381	Q9Y5W8
RFMVNQMENEGRGFE	SPHKAP	1131	Q2M3C7
AGVNQRMDSYAHMNG	SOX2	151	P48431
MYRNFQMEVLSGEQN	TRMT5	246	Q32P41
DLDNNVAFIGMYQTM	SIDT2	211	Q8NBJ9
TMENQIHTGMEYDNG	SV2C	486	Q496J9
ERAMFINYEQVNMGD	LCMT1	221	Q9UIC8
AGQAEFTAMREQYMR	RIT2	76	Q99578
MTRNAMAYNVQQGFA	TAF1	441	P21675
QLVAMQRGVAAAMQY	EPHB6	771	O15197
AVLVDGMLYSGTMNN	SEMA4A	186	Q9H3S1
NGQQAALASQYRAMM	PRRC2C	231	Q9Y520
GQEEFGAMREQYMRT	RRAS2	71	P62070
RNTYQSAMGKQAMGV	POLR2B	721	P30876
YGQDVDGHNFIMRMN	ST3GAL2	166	Q16842
EMQGGQMYLYIQEVA	SLC5A3	431	P53794
NMAGGDMARVSTYTN	SLC43A3	306	Q8NBI5
AAAAMMQEAQLAYGQ	SOX1	201	O00570
NCAIGMVFTMEAGNY	SLC6A20	441	Q9NP91
ENGLNYMAVAFAMQL	CNOT1	1751	A5YKK6
TMCGQGMQAFDYLEA	TSPAN33	201	Q86UF1
IYTVMENNSGRMYGA	RIN2	681	Q8WYP3
YRLRDGTGNQMLQVM	VPS13A	3051	Q96RL7
SALAAMQQFYGINMT	MMP16	71	P51512
MQQFYGINMTGKVDR	MMP16	76	P51512
TAGQAEFTAMRDQYM	RIT1	76	Q92963
MQEMGNGKANRLYEA	SMAP2	81	Q8WU79
LTQMTQQMAGMNFYG	SMAP2	386	Q8WU79
QNQNYFMEVMTVEGV	SNX14	776	Q9Y5W7
SNMLSMENVGNYQGY	SPATA31D1	761	Q6ZQQ2
NNTVLFEGKYGGMQM	RORB	326	Q92753
SVNVIGQRMDFYAMI	PIEZO2	1131	Q9H5I5
TDQSLQAGGQFYVMM	USF2	186	Q15853
QAGGQFYVMMTPQDV	USF2	191	Q15853
ENFYQQQEGMEMEPG	ZC3H4	696	Q9UPT8
CNGRIMMARQTGVFY	ZDHHC14	51	Q8IZN3
NMNVMEEAIGYFEQQ	TTC28	846	Q96AY4
DVNGFMEYLRQNSQM	ZCCHC9	71	Q8N567
YMGVASLNGVQFMDR	SLC4A4	911	Q9Y6R1
GQEEFGAMREQYMRA	RRAS	86	P10301
MLQMAGQCSQNEYFD	TNFRSF17	1	Q02223
MNRAVSSNVGAYMQP	TFIP11	711	Q9UBB9
AGHESYQNMGPQRMN	ZNF638	56	Q14966
ARQGMMSARGDFLNY	UBR5	1906	O95071
DVMLENYGNMVSLGF	ZNF311	91	Q5JNZ3
EYVNGGDLMFHMQRQ	PRKCZ	331	Q05513
EDIINAYSGQNMGDM	MYO5A	121	Q9Y4I1
QDVIYTYSGQNMGDM	MYO5B	121	Q9ULV0
SMNVGDQFLLMYTAG	NACC1	91	Q96RE7
EIQGGYMDMYRRNQA	N4BP3	506	O15049
VYQFQVAAMNMAGLG	MYOM1	1006	P52179
MNRMAGIFDVNTCYG	NDC1	456	Q9BTX1
WNGMIGEVFYQRADM	GRIN2D	521	O15399